These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
160 related articles for article (PubMed ID: 22426151)
1. Postrepolarization refractoriness in acute ischemia and after antiarrhythmic drug administration. Pandit SV; Noujaim SF; Jalife J Heart Rhythm; 2012 May; 9(5):e13-4; author reply e14. PubMed ID: 22426151 [No Abstract] [Full Text] [Related]
2. Postrepolarization refractoriness: a mechanism in need for a molecule? Kirchhof P; Fabritz L Heart Rhythm; 2012 Jun; 9(6):983-4. PubMed ID: 22334152 [No Abstract] [Full Text] [Related]
3. Postrepolarization refractoriness in acute ischemia and after antiarrhythmic drug administration: action potential duration is not always an index of the refractory period. Coronel R; Janse MJ; Opthof T; Wilde AA; Taggart P Heart Rhythm; 2012 Jun; 9(6):977-82. PubMed ID: 22293142 [TBL] [Abstract][Full Text] [Related]
4. Reduction of dispersion of repolarization and prolongation of postrepolarization refractoriness explain the antiarrhythmic effects of quinidine in a model of short QT syndrome. Milberg P; Tegelkamp R; Osada N; Schimpf R; Wolpert C; Breithardt G; Borggrefe M; Eckardt L J Cardiovasc Electrophysiol; 2007 Jun; 18(6):658-64. PubMed ID: 17521304 [TBL] [Abstract][Full Text] [Related]
6. Postrepolarization refractoriness versus conduction slowing caused by class I antiarrhythmic drugs: antiarrhythmic and proarrhythmic effects. Kirchhof PF; Fabritz CL; Franz MR Circulation; 1998 Jun; 97(25):2567-74. PubMed ID: 9657478 [TBL] [Abstract][Full Text] [Related]
7. [Classification and mechanism of action of anti-arrhythmia drugs]. Gasic S Wien Med Wochenschr; 1994; 144(14-15):338-42. PubMed ID: 7825324 [TBL] [Abstract][Full Text] [Related]
8. Electrophysiology and pharmacology of cardiac arrhythmias. V. Cardiac antiarrhythmic effects of lidocaine. Rosen MR; Hoffman BF; Wit AL Am Heart J; 1975 Apr; 89(4):526-36. PubMed ID: 1090140 [No Abstract] [Full Text] [Related]
9. Class III drugs: their effects on arrhythmias and on the QT interval. Campbell R; Loaiza A Ann N Y Acad Sci; 1992 Jan; 644():223-34. PubMed ID: 1562116 [No Abstract] [Full Text] [Related]
10. The Relentless Pursuit of New Drugs to Treat Cardiac Arrhythmias. Kowey PR; Robinson VM Circulation; 2020 May; 141(19):1507-1509. PubMed ID: 32392105 [No Abstract] [Full Text] [Related]
11. [Effect of a new antiarrhythmic drug, bunaftine, on the bundle of His]. Scibilia G; Bonatti V; Pavarani A; Tagliavini S; Botti G Cardiol Prat; 1973; 24(1):79-84. PubMed ID: 4575451 [No Abstract] [Full Text] [Related]
12. The cardiac ion channels: relevance to management of arrhythmias. Roden DM; George AL Annu Rev Med; 1996; 47():135-48. PubMed ID: 8712768 [TBL] [Abstract][Full Text] [Related]
14. Ischemic modulation of vulnerable period and the effects of pharmacological treatment of ischemia-induced arrhythmias: a simulation study. Cimponeriu A; Starmer CF; Bezerianos A IEEE Trans Biomed Eng; 2003 Feb; 50(2):168-77. PubMed ID: 12665030 [TBL] [Abstract][Full Text] [Related]
15. New class III antiarrhythmic drugs. Katritsis D; Camm AJ Eur Heart J; 1993 Nov; 14 Suppl H():93-9. PubMed ID: 8293759 [TBL] [Abstract][Full Text] [Related]
16. Electrophysiological and antiarrhythmic effects of propranolol in canine acute myocardial ischemia. Kupersmith J; Shiang H; Litwak RS; Herman MV Circ Res; 1976 Apr; 38(4):302-7. PubMed ID: 1260972 [TBL] [Abstract][Full Text] [Related]
17. [Stimulation, stimulus conduction and myocardial excitability of the human heart under oxyfedrin therapy of bradycardic dysrhythmias (author's transl)]. Diewitz M Med Klin; 1974 May; 69(18):806-13. PubMed ID: 4151986 [No Abstract] [Full Text] [Related]